Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Vulvar premalignancies – A dermatologist’s perspective

View through CrossRef
Vulvar malignancies are rarely encountered in dermatology, yet it is imperative to develop a thorough clinical and diagnostic acumen, as early detection and appropriate treatment can improve quality of life or even prevent fatal outcome. The common premalignant vulvar lesions are vulvar intraepithelial neoplasia (VIN), vulvar Paget’s disease, and melanoma in situ. These are notable since they are associated with a high post-treatment recurrence rate. The incidence of VIN is increasing in younger women. Early diagnosis and tailoring the management on individual basis may help to reduce the long-term morbidity. This review describes etiology, clinical features, management, and prognosis of vulvar premalignancies.
Title: Vulvar premalignancies – A dermatologist’s perspective
Description:
Vulvar malignancies are rarely encountered in dermatology, yet it is imperative to develop a thorough clinical and diagnostic acumen, as early detection and appropriate treatment can improve quality of life or even prevent fatal outcome.
The common premalignant vulvar lesions are vulvar intraepithelial neoplasia (VIN), vulvar Paget’s disease, and melanoma in situ.
These are notable since they are associated with a high post-treatment recurrence rate.
The incidence of VIN is increasing in younger women.
Early diagnosis and tailoring the management on individual basis may help to reduce the long-term morbidity.
This review describes etiology, clinical features, management, and prognosis of vulvar premalignancies.

Related Results

Vulvar malignancies: an interdisciplinary perspective
Vulvar malignancies: an interdisciplinary perspective
SummaryVulvar cancer represents the fourth most common gynecologic malignancy and is often encountered by the general Dermatologist or Gynecologist. Dermatooncologists and Gynecolo...
Vulvar Dystrophies: An Evaluation
Vulvar Dystrophies: An Evaluation
EDITORIAL COMMENT: This paper provides readers with a logical plan of treatment for patients presenting with pruritus, vulvitis or visible vulvar disease who are found on directed...
Data from Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma
Data from Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma
<div>Abstract<p><b>Background:</b> The association between lichen sclerosus and vulvar squamous cell carcinoma (VSCC) has long been recognized, but large ep...
Data from Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma
Data from Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma
<div>Abstract<p><b>Background:</b> The association between lichen sclerosus and vulvar squamous cell carcinoma (VSCC) has long been recognized, but large ep...
Vulvar dermatofibrosarcoma protuberans, an unusual anatomical location
Vulvar dermatofibrosarcoma protuberans, an unusual anatomical location
Abstract Vulvar dermatofibrosarcoma protuberans (DFSP) is a rare pathology. So far, only limited number of cases have been reported in literature. In the present cas...
Evaluation of PD-L1 expression in vulvar cancer
Evaluation of PD-L1 expression in vulvar cancer
Background: The PD-1/PD-L1 inhibitory immune checkpoint seems to have a significant prognostic impact in the evolution of certain cancers such as bronchopulmonary cancer, breast ca...
Rare benign vulvar tumours: Case series
Rare benign vulvar tumours: Case series
Vulvar tumours are rare benign lesions of the lower genital tract, frequently prompting gynaecological consultations. This case series explores three distinct presentations: vulvar...
Vulvar cancer: brain metastases. Clinical observation
Vulvar cancer: brain metastases. Clinical observation
Introduction. Brain metastases can occur in almost all gynecological malignancies and, despite modern therapeutic options, have a poor prognosis. Brain metastases from vulvar cance...

Back to Top